Dr. Reddy's Laboratories Ltd. announced its launch of Doxycycline Capsules, 40 mg in the U.S. market, a therapeutic generic equivalent of ORACEA® (doxycycline, USP) Capsules, 40 mg approved by the U.S. Food and Drug Administration (USFDA).

Dr. Reddy's Doxycycline Capsules, 40 mg, are supplied in bottle counts of 30.

Each capsule contains: 26 mg immediate-release pellets and 14 mg delayed-release pellets equivalent to 40 mg of anhydrous doxycycline, USP.

ORACEA is a trademark of Galderma Holdings, S.A.